CAR19 Donor Lymphocytes for Relapsed CD19+ Malignancies Following Allogeneic Transplantation
Clinical trial NCT02893189 · COMPLETED
Trial details
- NCT number
- NCT02893189
- Sponsor
- University College, London
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-27
- Primary completion
- 2019-12-31
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.